Entia Biosciences Inc. (ERGO)

Last Closing Price: --

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Entia Biosciences Inc. (ERGO) had Net Income of $-0.43M for the most recently reported fiscal quarter, ending 2016-12-31.

Figures for fiscal quarter ending 2016-12-31
Income Statement Financials
$0.05M
Net Income
$-0.43M
$0.01M
$0.04M
$0.43M
$-0.39M
$-0.05M
$-0.43M
$-0.43M
$-0.43M
$-0.43M
$-0.43M
$-0.43M
$-0.39M
$-0.31M
28.14M
28.14M
$-0.02
$-0.02
Balance Sheet Financials
$0.23M
$0.02M
$0.20M
$0.44M
$2.11M
$0.30M
$0.30M
$2.41M
$-1.97M
$-2.15M
$-1.97M
28.15M
Cash Flow Statement Financials
$-0.72M
$-0.01M
$0.77M
$0.02M
$0.08M
$0.05M
$0.11M
--
--
Fundamental Metrics & Ratios
0.11
--
--
-0.18
-0.53
77.99%
-838.61%
-838.61%
--
-941.12%
-941.12%
$-0.72M
--
--
--
0.10
0.15
5.77
15.60
22.00%
20.10%
-98.55%
25.97%
$-0.07
$-0.03
$-0.03